Dental composites with improved storage stability

US11357708B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-11357708-B2
Application numberUS-201615541257-A
CountryUS
Kind codeB2
Filing dateJan 8, 2016
Priority dateJan 9, 2015
Publication dateJun 14, 2022
Grant dateJun 14, 2022

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Dental material which contains (a) at least one mono- or multifunctional radically polymerizable monomer, (b) at least one organic halogen compound as initiator for the radical polymerization, (c) at least one transition metal compound as catalyst and (d) at least one reducing agent. The material is characterized by a high storage stability at room temperature and does not have the disadvantages associated with peroxides.

First claim

Opening claim text (preview).

The invention claimed is: 1. Dental material comprising (a) a mixture of at least one mono- and at least one polyfunctional methacrylate as radically polymerizable monomer, (b) at least one organic halogen compound, (c) at least one transition metal compound, and (d) at least one reducing agent, wherein said dental material does not comprise peroxides or solvents, wherein the transition metal compound is a compound of copper, iron, ruthenium, nickel or palladium and wherein the at least one halogen compound (b) is selected from halogenated alkyl aromatics, benzyl halides, benzyl chloride, benzyl bromide, 1-phenylethyl chloride, benzotrichloride, benzhydryl chloride, benzhydryl bromide; α-halogen carboxylic acid esters, C 1 -C 6 -alkyl esters of an α-halogen-C 1 -C 6 -carboxylic acid, α-chloropropionic acid, α-bromopropionic acid, α-chloro-isobutanoic acid, α-bromo-iso-butanoic acid, α-bromophenylacetic acid, esters of α-bromo-isobutanoic acid, α-bromo-isobutanoic acid methylester, α-bromo-isobutanoic acid ethylester, α-bromo-iso-butyryl bromide, 2-(2-bromoisobutyryloxy)ethyl methacrylate, tert-butyl α-bromoisobutyrate, 3-butynyl-2-bromo-iso-butyrate, dipentaerythritol hexakis(2-bromoisobutyrate), 1,1,1-tris(2-bromoisobutyryloxymethyl)ethane, ethyl α-bromophenylacetate; α-halogenketones, 1,1,1-trichloropropan-2-one, dichloromethyl phenyl ketone; α-halogen nitriles, 2-bromopropionitrile, trichloroacetonitrile; sulphonyl halides, methylsulphonyl chloride, trichloromethylsulphonyl chloride, p-toluenesulphonyl chloride and 4-methoxyphenylsulphonyl chloride. 2. Dental material according to claim 1 further comprising at least one organic and/or inorganic filler as constituent (e). 3. Dental material according to claim 1 comprising as monomer (a) a mixture of mono- and difunctional methacrylates. 4. Dental material according to claim 1 comprising as component (c) at least one transition metal complex compound which is selected from the complexes of the metals copper, iron, ruthenium, nickel and palladium; copper complexes with the ligands phenanthroline, 1,10-phenanthroline (Phen), terpyridine, bipyridine, 2,2′-bipyridine (Bipy), 4,4′-dimethyl-2,2′-bipyridine, 6,6′-dimethyl-2,2′-bipyridine, pyridinimine, aliphatic amines, 1,1,4,7,10,10-hexamethyltriethylenetetramine (HMTETA), N,N,N′,N″,N″-penta-methyldiethylenetriamine (PMDETA) and tris[2-(dimethylamino)ethyl]amine (Me 6 TREN); iron complexes with the ligands triphenylphosphine, 4,4′-di(5-nonyl)-2,2′-bipyridine (dNbpy) or 1,3-diisopropyl-4,5-dimethylimidazol-2-ylidene (PriIm), FeCl 2 (PPh 3 ) 2 , FeBR 2 -dNbpy (dNbpy: 4,4′-di(5-nonyl)-2,2′-bipyridine), FeC 2 (PriIm) 2 and FeBr 2 (PriIm) 2 (PriIm: 1,3-diisopropyl-4,5-dimethylimidazol-2-ylidene); the ruthenium complexes RuCl 2 (PPh 3 ) 4 and RuH 2 (PPh 3 ) 4 ; or the nickel complexes Ni[o,o′(CH 2 NMe 2 )C 6 H 3 ]Br and NiBr 2 (PPh 3 ) 2 . 5. Dental material comprising (a) a mixture of at least one mono- and at least one polyfunctional methacrylate as radically polymerizable monomer, (b) at least one organic halogen compound, (c) at least one transition metal compound, and (d) at least one reducing agent, wherein said dental material does not comprise peroxides or solvents, wherein the at least one transition metal compound is a transition metal salt which is selected from the salts of the metals copper, iron, ruthenium, nickel and palladium, CuCl, CuBr, CuCl 2 , CuBr 2 , CuI 2 , Cu(II) carboxylates, Cu(II) acetate, Cu(II)-2-ethylhexanoate, FeCl 3 , FeBr 2 , FeCl 2 , RuCl 2 , NiBr 2 , NiCl 2 , Pd(OAc) 2 and wherein the dental material additionally comprises at least one complexing organic compound which is selected from P- and N-containing ligands, phosphines, triphenylphosphine; ethylenediaminetetraacetic acid (EDTA); phenanthrolines, 1,10-phenanthroline (Phen); bipyridines, 2,2′-bipyridine (Bipy), 4,4′-dimethyl-2,2′-bipyridine, 6,6′-dimethyl-2,2′-bipyridine and 4,4′-di(5-nonyl)-2,2′-bipyridine (dNbpy); terpyridines, 2′:6′,2″-terpyridine (tpy), 4,4′,4″-tris(5-nonyl)-2,2′:6′,2″-terpyridine; pyridinimines, N-octyl-2-pyridylmethanimine; alkylated imidazoles, 1,3-diisopropyl-4,5-dimethylimidazol-2-ylidene (PriIm); alkylamino-substituted benzenes, o,o′(CH 2 NMe 2 ) 2 C 6 H 3 ; aliphatic amines, 1,1,4,7,10,10-hexamethyltriethylenetetramine (HMTETA), N,N,N′,N″,N″-pentamethyldiethylenetriamine (PMDETA), tris[2-(dimethylamino)ethyl]amine (Me 6 TREN), N,N,N′,N′-tetramethylethylenediamine (TMEDA), 1,4,8,11-tetraaza-1,4,8,11-tetramethylcyclotetradecane (Me4CYCLAM), diethylenetriamine (DETA), triethylenetetramine (TETA) and 1,4,8,11-tetraazacyclotetradecane (CYCLAM)); pyridine-containing ligands, N,N,N′,N′-tetrakis(2-pyridylmethyl)ethylenediamine (TPEN), N,N-bis(2-pyridylmethyl)amine (BPMA) and N,N-bis(2-pyridylmethyl)octylamine (BPMOA), alkyl-substituted 2-(1H-1,2,3-triazol-4-yl)pyridines, 2,6-bis(1H-1,2,3-triazol-4-yl)-pyridine and alkyl-substituted 2,6-bis(1H-1,2,3-triazol-4-yl)pyridines. 6. Dental material according to claim 1 comprising as reducing agent (d) at least one compound which is selected from ascorbic acid and derivatives thereof, tin compounds, Sn(II) octoate, Sn(II)-2-ethylhexanoate, reducing sugars, glucose, fructose, antioxidants, β-carotenoids, vitamin A, α-tocopherol (vitamin E), phenolic reducing agents, butylhydroxytoluene (BHT), butylhydroxyanisole (BHA), propyl gallate, octyl gallate, pyrogallol, sulphites, bisulphites, thiosulphates, hydroxylamine, hydrazine and derivatives thereof. 7. Dental material according to claim 1 further comprising a photoinitiator. 8. Dental material according to claim 1 comprising no plasticizers/phlegmatizing agents. 9. Dental material comprising (a) 5 to 80 wt.-% of a mixture of at least one mono- and at least one polyfunctional methacrylate as radically polymerizable monomer, (b) 0.1 to 6.0 wt.-% of at least one organic halogen compound, (c) 0.0001 to 1.0 wt.-% of at least one transition metal compound, (d) 0.01 to 5.0 wt.-% of at least one reducing agent and (e) 10 to 85 wt.-% filler(s), wherein said dental material does not comprise peroxides or solvents, wherein the transition metal compound is a compound of copper, iron, ruthenium, nickel or palladium and wherein, if constituent (c) is a non-complex transition metal salt, then the dental material additionally contains 0.0001 to 1.0 wt.-% of at least one complexing organic compound. 10. Dental material according to claim 9 , which additionally comprises (f) 0.01 to 3.0 wt.-% photoinitiator, and/or (g) 0.001 to 5.0 wt.-% additive(s). 11. Dental material according to claim 10 which is present in the form of at least two separate components which are mixed with each other before use. 12. Dental material according to claim 11 which comprises a first component and a second component, wherein the first component contains the constituents (a), (c) and optionally one or more of the constituents (f)-(g) and the second component contains the constituents (a), (b), (d), (e) and optionally one or more of the constituents (f)-(g). 13. Dental material according to claim 1 for use as cement or filling material. 14. Dental material according to claim 1 manufactured into dental restorations, inlays, onlays, crowns or bridges. 15. Dental material according to claim 9 comprising (a) 10 to 70 wt.-% mono- and polyfunctional (meth)acrylates, (b) 0.2 to 4.0 wt.-% of at least one organic halogen compound, (c) 0.001 to 1.0 wt.-% of at least one transition metal compound, (d) 0.01 to 3.0 wt.-% reducing agent and (e) 22 to 82 wt.-% filler(s), wherein, if constituent (c) is a non-complex transition metal salt, then the d

Assignees

Inventors

Classifications

  • A61K6/61Primary

    Cationic, anionic or redox initiators · CPC title

  • A61K6/887Primary

    Compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds · CPC title

  • Photochemical radical initiators · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11357708B2 cover?
Dental material which contains (a) at least one mono- or multifunctional radically polymerizable monomer, (b) at least one organic halogen compound as initiator for the radical polymerization, (c) at least one transition metal compound as catalyst and (d) at least one reducing agent. The material is characterized by a high storage stability at room temperature and does not have the disadvantage…
Who is the assignee on this patent?
Ivoclar Vivadent Ag
What technology area does this patent fall under?
Primary CPC classification A61K6/61. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Jun 14 2022 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).